BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29279241)

  • 21. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases.
    Imai R; Kamada T; Araki N;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):322-327. PubMed ID: 27084649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
    Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors of acute skin reactions to carbon ion radiotherapy for the treatment of malignant bone and soft tissue tumors.
    Takakusagi Y; Saitoh JI; Kiyohara H; Oike T; Noda SE; Ohno T; Nakano T
    Radiat Oncol; 2017 Nov; 12(1):185. PubMed ID: 29166945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
    Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
    Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
    Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
    Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-weighted magnetic resonance imaging in painful bone metastases: Using quantitative apparent diffusion coefficient as an indicator of effectiveness of single fraction versus multiple fraction radiotherapy.
    Musio D; De Francesco I; Galdieri A; Marsecano C; Piciocchi A; Napoli A; De Felice F; Tombolini V
    Eur J Radiol; 2018 Jan; 98():1-6. PubMed ID: 29279145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic spacer placement for recurrent sacral chordoma before carbon ion radiotherapy: A case report.
    Nagai S; Nagayoshi K; Mizuuchi Y; Fujita H; Ohuchida K; Ohtsuka T; Imai R; Nakamura M
    Asian J Endosc Surg; 2020 Oct; 13(4):582-585. PubMed ID: 32097984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
    Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
    Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
    Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J;
    Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rectal dose-sparing effect with bioabsorbable spacer placement in carbon ion radiotherapy for sacral chordoma: dosimetric comparison of a simulation study.
    Shiba S; Okamoto M; Tashiro M; Ogawa H; Osone K; Yanagawa T; Kohama I; Okazaki S; Miyasaka Y; Osu N; Chikuda H; Saeki H; Ohno T
    J Radiat Res; 2021 May; 62(3):549-555. PubMed ID: 33783533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma.
    Santos P; Peck KK; Arevalo-Perez J; Karimi S; Lis E; Yamada Y; Holodny AI; Lyo J
    AJNR Am J Neuroradiol; 2017 Nov; 38(11):2210-2216. PubMed ID: 28912284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectotumoral fistula formation occurring more than 5 years after carbon ion radiotherapy for sacral chordoma: A case report.
    Ukon Y; Outani H; Nagata S; Konishi E; Imai R; Demizu Y; Okimoto T; Naka N; Araki N
    Mol Clin Oncol; 2019 May; 10(5):487-491. PubMed ID: 30967943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features.
    Amini B; Chenglei L; Duran-Sierra E; Wang WL; Canjirathinkal MA; Moradi H; Green WN; Madewell JE; Costelloe CM; Murphy WA; Valenzuela RF
    JCO Precis Oncol; 2023 Sep; 7():e2300243. PubMed ID: 38127828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
    Wu X; Nerisho S; Dastidar P; Ryymin P; Järvenpää R; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
    NMR Biomed; 2013 Sep; 26(9):1186-94. PubMed ID: 23483722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.
    Cheney MD; Chen YL; Lim R; Winrich BK; Grosu AL; Trofimov AV; Depauw N; Shih HA; Schwab JH; Hornicek FJ; DeLaney TF
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1030-6. PubMed ID: 25539367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosimetric effect of variable rectum and sigmoid colon filling during carbon ion radiotherapy to sacral chordoma.
    Ricotti R; Pella A; Mirandola A; Fiore MR; Chalaszczyk A; Paganelli C; Antonioli L; Vai A; Tagaste B; Belotti G; Rossi M; Ciocca M; Orlandi E; Baroni G
    Phys Med; 2021 Oct; 90():123-133. PubMed ID: 34628271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of high dose carbon-ion radiation therapy for unresectable upper cervical (C1-2) chordoma.
    Aoki S; Koto M; Ikawa H; Imai R; Tokuhiko O; Shinoto M; Takiyama H; Yamada S; Tsuji H
    Head Neck; 2022 Oct; 44(10):2162-2170. PubMed ID: 35734902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.